Cargando…
Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectives
Hyponatremia is the most frequently observed electrolyte abnormality in clinical practice, and its frequency is almost double in hospitalized cancer patients. As a subset of cancer, hyponatremia is quite common in lung cancer patients, and it is often coupled with the diagnosis of syndrome of inappr...
Autores principales: | Thajudeen, Bijin, Salahudeen, Abdulla K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001656/ https://www.ncbi.nlm.nih.gov/pubmed/27578998 http://dx.doi.org/10.2147/CMAR.S90169 |
Ejemplares similares
-
Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011) -
Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008) -
Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations
por: Murugapandian, Sangeetha, et al.
Publicado: (2015) -
Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010) -
Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)